Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trialMehreen S. Datoo, Halidou Tinto, Matthew Cairns et al.|The Lancet|2021Cited by 457
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialMehreen S. Datoo, Halidou Tinto, Hamtandi Magloire Natama et al.|The Lancet Infectious Diseases|2022Cited by 285
Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort studyHamtandi Magloire Natama, Anna Rosanas‐Urgell, Eduard Rovira-Vallbona et al.|Malaria Journal|2018Cited by 47
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled TrialSusana Scott, Franco Pagnoni, Umberto D’Alessandro et al.|Clinical Infectious Diseases|2018Cited by 43
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of lifeHamtandi Magloire Natama, Anna Rosanas‐Urgell, Gemma Moncunill et al.|BMC Medicine|2018Cited by 38